| Abstrakt: |
This document provides information about a clinical trial for a topical gel called SM-030. The trial aims to evaluate the effectiveness and safety of two different concentrations of the gel in treating melasma, a skin condition characterized by hyperpigmentation. The trial is currently recruiting participants and is expected to be completed in July 2025. The eligibility criteria for participants are outlined, including age, skin type, and previous treatments. The document also includes administrative information such as the study ID number and the responsible party. [Extracted from the article] |
